APO Research
Talk to an analyst

APO RESEARCH · REPORT

Alpha N-Acetylglucosaminidase

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Alpha N-Acetylglucosaminidase Market Outlook and Growth Opportunities 2026

19 December 2025193 pages

Choose your research edition.

Industry ResearchAlpha N-Acetylglucosaminidase Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Alpha N-Acetylglucosaminidase Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Alpha N-Acetylglucosaminidase Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Alpha N-Acetylglucosaminidase Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Alpha N-Acetylglucosaminidase Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Alpha N-Acetylglucosaminidase market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Alpha N-Acetylglucosaminidase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Alpha N-Acetylglucosaminidase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Alpha N-Acetylglucosaminidase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Alpha N-Acetylglucosaminidase market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Alpha N-Acetylglucosaminidase market include UniQure N.V., Laboratorios Del Dr. Esteve S.A., Dorphan S.A., BioMarin Pharmaceutical Inc., Alexion Pharmaceuticals, Inc. and Abeona Therapeutics, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Alpha N-Acetylglucosaminidase market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Alpha N-Acetylglucosaminidase and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Alpha N-Acetylglucosaminidase sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Alpha N-Acetylglucosaminidase market size, projected growth trends, production technologies, key applications, and end-use industries.

Alpha N-Acetylglucosaminidase Segment by Company

UniQure N.V.

Laboratorios Del Dr. Esteve S.A.

Dorphan S.A.

BioMarin Pharmaceutical Inc.

Alexion Pharmaceuticals, Inc.

Abeona Therapeutics, Inc.

Alpha N-Acetylglucosaminidase Segment by Type

Lesinidase Alfa

EGT-201

BMN-250

ABO-101

Others

Alpha N-Acetylglucosaminidase Segment by Application

In-Patient

Out-Patient

Alpha N-Acetylglucosaminidase Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Alpha N-Acetylglucosaminidase status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Alpha N-Acetylglucosaminidase market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Alpha N-Acetylglucosaminidase significant trends, drivers, influence factors in global and regions.

6. To analyze Alpha N-Acetylglucosaminidase competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Alpha N-Acetylglucosaminidase market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Alpha N-Acetylglucosaminidase and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Alpha N-Acetylglucosaminidase.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Alpha N-Acetylglucosaminidase market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Alpha N-Acetylglucosaminidase industry.

Chapter 3: Detailed analysis of Alpha N-Acetylglucosaminidase manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Alpha N-Acetylglucosaminidase in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Alpha N-Acetylglucosaminidase in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Alpha N-Acetylglucosaminidase Industry Trends Table 2. Alpha N-Acetylglucosaminidase Industry Drivers Table 3. Alpha N-Acetylglucosaminidase Industry Opportunities and Challenges Table 4. Alpha N-Acetylglucosaminidase Industry Restraints Table 5. Global Alpha N-Acetylglucosaminidase Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Alpha N-Acetylglucosaminidase Revenue Share by Company (2021-2026) Table 7. Global Alpha N-Acetylglucosaminidase Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Alpha N-Acetylglucosaminidase Sales Volume Share by Company (2021-2026) Table 9. Global Alpha N-Acetylglucosaminidase Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Alpha N-Acetylglucosaminidase Company Ranking, (2024-2026) & (USD Million) Table 11. Global Alpha N-Acetylglucosaminidase Key Company Manufacturing Base & Headquarters Table 12. Global Alpha N-Acetylglucosaminidase Company, Product Type & Application Table 13. Global Alpha N-Acetylglucosaminidase Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Alpha N-Acetylglucosaminidase by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Lesinidase Alfa Table 18. Significant Companies of EGT-201 Table 19. Significant Companies of BMN-250 Table 20. Significant Companies of ABO-101 Table 21. Significant Companies of Others Table 22. Global Alpha N-Acetylglucosaminidase Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 23. Global Alpha N-Acetylglucosaminidase Sales Volume by Type (2021-2026) & (K Units) Table 24. Global Alpha N-Acetylglucosaminidase Sales Volume by Type (2027-2032) & (K Units) Table 25. Global Alpha N-Acetylglucosaminidase Sales Volume Share by Type (2021-2026) Table 26. Global Alpha N-Acetylglucosaminidase Sales Volume Share by Type (2027-2032) Table 27. Global Alpha N-Acetylglucosaminidase Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Alpha N-Acetylglucosaminidase Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Alpha N-Acetylglucosaminidase Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Alpha N-Acetylglucosaminidase Sales Value Share by Type (2021-2026) Table 31. Global Alpha N-Acetylglucosaminidase Sales Value Share by Type (2027-2032) Table 32. Significant Companies of In-Patient Table 33. Significant Companies of Out-Patient Table 34. Global Alpha N-Acetylglucosaminidase Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Alpha N-Acetylglucosaminidase Sales Volume by Application (2021-2026) & (K Units) Table 36. Global Alpha N-Acetylglucosaminidase Sales Volume by Application (2027-2032) & (K Units) Table 37. Global Alpha N-Acetylglucosaminidase Sales Volume Share by Application (2021-2026) Table 38. Global Alpha N-Acetylglucosaminidase Sales Volume Share by Application (2027-2032) Table 39. Global Alpha N-Acetylglucosaminidase Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Alpha N-Acetylglucosaminidase Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Alpha N-Acetylglucosaminidase Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Alpha N-Acetylglucosaminidase Sales Value Share by Application (2021-2026) Table 43. Global Alpha N-Acetylglucosaminidase Sales Value Share by Application (2027-2032) Table 44. Global Alpha N-Acetylglucosaminidase Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Alpha N-Acetylglucosaminidase Sales by Region (2021-2026) & (K Units) Table 46. Global Alpha N-Acetylglucosaminidase Sales Market Share by Region (2021-2026) Table 47. Global Alpha N-Acetylglucosaminidase Sales by Region (2027-2032) & (K Units) Table 48. Global Alpha N-Acetylglucosaminidase Sales Market Share by Region (2027-2032) Table 49. Global Alpha N-Acetylglucosaminidase Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Alpha N-Acetylglucosaminidase Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Alpha N-Acetylglucosaminidase Sales Value Share by Region (2021-2026) Table 52. Global Alpha N-Acetylglucosaminidase Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Alpha N-Acetylglucosaminidase Sales Value Share by Region (2027-2032) Table 54. Global Alpha N-Acetylglucosaminidase Market Average Price (US$/Unit) by Region (2021-2026) Table 55. Global Alpha N-Acetylglucosaminidase Market Average Price (US$/Unit) by Region (2027-2032) Table 56. Global Alpha N-Acetylglucosaminidase Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Global Alpha N-Acetylglucosaminidase Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Alpha N-Acetylglucosaminidase Sales by Country (2021-2026) & (K Units) Table 59. Global Alpha N-Acetylglucosaminidase Sales Market Share by Country (2021-2026) Table 60. Global Alpha N-Acetylglucosaminidase Sales by Country (2027-2032) & (K Units) Table 61. Global Alpha N-Acetylglucosaminidase Sales Market Share by Country (2027-2032) Table 62. Global Alpha N-Acetylglucosaminidase Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Alpha N-Acetylglucosaminidase Sales Value Market Share by Country (2021-2026) Table 64. Global Alpha N-Acetylglucosaminidase Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Alpha N-Acetylglucosaminidase Sales Value Market Share by Country (2027-2032) Table 66. UniQure N.V. Company Information Table 67. UniQure N.V. Business Overview Table 68. UniQure N.V. Alpha N-Acetylglucosaminidase Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. UniQure N.V. Alpha N-Acetylglucosaminidase Product Portfolio Table 70. UniQure N.V. Recent Development Table 71. Laboratorios Del Dr. Esteve S.A. Company Information Table 72. Laboratorios Del Dr. Esteve S.A. Business Overview Table 73. Laboratorios Del Dr. Esteve S.A. Alpha N-Acetylglucosaminidase Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Laboratorios Del Dr. Esteve S.A. Alpha N-Acetylglucosaminidase Product Portfolio Table 75. Laboratorios Del Dr. Esteve S.A. Recent Development Table 76. Dorphan S.A. Company Information Table 77. Dorphan S.A. Business Overview Table 78. Dorphan S.A. Alpha N-Acetylglucosaminidase Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Dorphan S.A. Alpha N-Acetylglucosaminidase Product Portfolio Table 80. Dorphan S.A. Recent Development Table 81. BioMarin Pharmaceutical Inc. Company Information Table 82. BioMarin Pharmaceutical Inc. Business Overview Table 83. BioMarin Pharmaceutical Inc. Alpha N-Acetylglucosaminidase Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. BioMarin Pharmaceutical Inc. Alpha N-Acetylglucosaminidase Product Portfolio Table 85. BioMarin Pharmaceutical Inc. Recent Development Table 86. Alexion Pharmaceuticals, Inc. Company Information Table 87. Alexion Pharmaceuticals, Inc. Business Overview Table 88. Alexion Pharmaceuticals, Inc. Alpha N-Acetylglucosaminidase Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Alexion Pharmaceuticals, Inc. Alpha N-Acetylglucosaminidase Product Portfolio Table 90. Alexion Pharmaceuticals, Inc. Recent Development Table 91. Abeona Therapeutics, Inc. Company Information Table 92. Abeona Therapeutics, Inc. Business Overview Table 93. Abeona Therapeutics, Inc. Alpha N-Acetylglucosaminidase Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Abeona Therapeutics, Inc. Alpha N-Acetylglucosaminidase Product Portfolio Table 95. Abeona Therapeutics, Inc. Recent Development Table 96. Key Raw Materials Table 97. Raw Materials Key Suppliers Table 98. Alpha N-Acetylglucosaminidase Distributors List Table 99. Alpha N-Acetylglucosaminidase Customers List Table 100. Research Programs/Design for This Report Table 101. Authors List of This Report Table 102. Secondary Sources Table 103. Primary Sources List of Figures Figure 1. Alpha N-Acetylglucosaminidase Product Image Figure 2. Global Alpha N-Acetylglucosaminidase Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Alpha N-Acetylglucosaminidase Sales Value (2021-2032) & (US$ Million) Figure 4. Global Alpha N-Acetylglucosaminidase Sales (2021-2032) & (K Units) Figure 5. Global Alpha N-Acetylglucosaminidase Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Alpha N-Acetylglucosaminidase Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Lesinidase Alfa Image Figure 10. EGT-201 Image Figure 11. BMN-250 Image Figure 12. ABO-101 Image Figure 13. Others Image Figure 14. Global Alpha N-Acetylglucosaminidase Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Alpha N-Acetylglucosaminidase Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Alpha N-Acetylglucosaminidase Sales Volume Share by Type (2021-2032) Figure 17. Global Alpha N-Acetylglucosaminidase Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Alpha N-Acetylglucosaminidase Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Alpha N-Acetylglucosaminidase Sales Value Share by Type (2021-2032) Figure 20. In-Patient Image Figure 21. Out-Patient Image Figure 22. Global Alpha N-Acetylglucosaminidase Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Alpha N-Acetylglucosaminidase Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Alpha N-Acetylglucosaminidase Sales Volume Share by Application (2021-2032) Figure 25. Global Alpha N-Acetylglucosaminidase Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Alpha N-Acetylglucosaminidase Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Alpha N-Acetylglucosaminidase Sales Value Share by Application (2021-2032) Figure 28. Global Alpha N-Acetylglucosaminidase Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 29. Global Alpha N-Acetylglucosaminidase Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Alpha N-Acetylglucosaminidase Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Alpha N-Acetylglucosaminidase Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Alpha N-Acetylglucosaminidase Sales Value (2021-2032) & (US$ Million) Figure 33. North America Alpha N-Acetylglucosaminidase Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Alpha N-Acetylglucosaminidase Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Alpha N-Acetylglucosaminidase Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Alpha N-Acetylglucosaminidase Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Alpha N-Acetylglucosaminidase Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Alpha N-Acetylglucosaminidase Sales Value (2021-2032) & (US$ Million) Figure 39. South America Alpha N-Acetylglucosaminidase Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Alpha N-Acetylglucosaminidase Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Alpha N-Acetylglucosaminidase Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Alpha N-Acetylglucosaminidase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Alpha N-Acetylglucosaminidase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Alpha N-Acetylglucosaminidase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Alpha N-Acetylglucosaminidase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Alpha N-Acetylglucosaminidase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Alpha N-Acetylglucosaminidase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Alpha N-Acetylglucosaminidase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Alpha N-Acetylglucosaminidase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Alpha N-Acetylglucosaminidase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Alpha N-Acetylglucosaminidase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Alpha N-Acetylglucosaminidase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Alpha N-Acetylglucosaminidase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Alpha N-Acetylglucosaminidase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Alpha N-Acetylglucosaminidase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Alpha N-Acetylglucosaminidase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Alpha N-Acetylglucosaminidase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Alpha N-Acetylglucosaminidase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Alpha N-Acetylglucosaminidase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Alpha N-Acetylglucosaminidase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Alpha N-Acetylglucosaminidase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Alpha N-Acetylglucosaminidase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Alpha N-Acetylglucosaminidase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Alpha N-Acetylglucosaminidase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Alpha N-Acetylglucosaminidase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Alpha N-Acetylglucosaminidase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Alpha N-Acetylglucosaminidase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Alpha N-Acetylglucosaminidase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Alpha N-Acetylglucosaminidase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Alpha N-Acetylglucosaminidase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Alpha N-Acetylglucosaminidase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Alpha N-Acetylglucosaminidase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Alpha N-Acetylglucosaminidase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Alpha N-Acetylglucosaminidase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Alpha N-Acetylglucosaminidase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Alpha N-Acetylglucosaminidase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Alpha N-Acetylglucosaminidase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Alpha N-Acetylglucosaminidase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Alpha N-Acetylglucosaminidase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Alpha N-Acetylglucosaminidase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Alpha N-Acetylglucosaminidase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Alpha N-Acetylglucosaminidase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Alpha N-Acetylglucosaminidase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Alpha N-Acetylglucosaminidase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Alpha N-Acetylglucosaminidase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Alpha N-Acetylglucosaminidase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Alpha N-Acetylglucosaminidase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Alpha N-Acetylglucosaminidase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Alpha N-Acetylglucosaminidase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Alpha N-Acetylglucosaminidase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Alpha N-Acetylglucosaminidase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Alpha N-Acetylglucosaminidase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Alpha N-Acetylglucosaminidase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Alpha N-Acetylglucosaminidase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Alpha N-Acetylglucosaminidase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Alpha N-Acetylglucosaminidase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Alpha N-Acetylglucosaminidase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Alpha N-Acetylglucosaminidase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Alpha N-Acetylglucosaminidase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Alpha N-Acetylglucosaminidase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Alpha N-Acetylglucosaminidase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Alpha N-Acetylglucosaminidase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Alpha N-Acetylglucosaminidase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Alpha N-Acetylglucosaminidase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Alpha N-Acetylglucosaminidase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Alpha N-Acetylglucosaminidase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Alpha N-Acetylglucosaminidase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Alpha N-Acetylglucosaminidase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Alpha N-Acetylglucosaminidase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Alpha N-Acetylglucosaminidase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Alpha N-Acetylglucosaminidase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Alpha N-Acetylglucosaminidase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Alpha N-Acetylglucosaminidase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Alpha N-Acetylglucosaminidase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Alpha N-Acetylglucosaminidase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Alpha N-Acetylglucosaminidase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Alpha N-Acetylglucosaminidase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Alpha N-Acetylglucosaminidase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Alpha N-Acetylglucosaminidase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Alpha N-Acetylglucosaminidase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Alpha N-Acetylglucosaminidase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Alpha N-Acetylglucosaminidase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Alpha N-Acetylglucosaminidase Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Alpha N-Acetylglucosaminidase Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Alpha N-Acetylglucosaminidase Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Alpha N-Acetylglucosaminidase Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Alpha N-Acetylglucosaminidase Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Lesinidase Alfa
  • EGT-201
  • BMN-250
  • ABO-101
  • Others
Applications
  • In-Patient
  • Out-Patient
Companies covered
  • UniQure N.V.
  • Laboratorios Del Dr. Esteve S.A.
  • Dorphan S.A.
  • BioMarin Pharmaceutical Inc.
  • Alexion Pharmaceuticals, Inc.
  • Abeona Therapeutics, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Alpha N-Acetylglucosaminidase Sales Value (2021-2032)
  4. 1.2.2 Global Alpha N-Acetylglucosaminidase Sales Volume (2021-2032)
  5. 1.2.3 Global Alpha N-Acetylglucosaminidase Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Alpha N-Acetylglucosaminidase Market Dynamics
  1. 2.1 Alpha N-Acetylglucosaminidase Industry Trends
  2. 2.2 Alpha N-Acetylglucosaminidase Industry Drivers
  3. 2.3 Alpha N-Acetylglucosaminidase Industry Opportunities and Challenges
  4. 2.4 Alpha N-Acetylglucosaminidase Industry Restraints
3 Alpha N-Acetylglucosaminidase Market by Company
  1. 3.1 Global Alpha N-Acetylglucosaminidase Company Revenue Ranking in 2025
  2. 3.2 Global Alpha N-Acetylglucosaminidase Revenue by Company (2021-2026)
  3. 3.3 Global Alpha N-Acetylglucosaminidase Sales Volume by Company (2021-2026)
  4. 3.4 Global Alpha N-Acetylglucosaminidase Average Price by Company (2021-2026)
  5. 3.5 Global Alpha N-Acetylglucosaminidase Company Ranking (2024-2026)
  6. 3.6 Global Alpha N-Acetylglucosaminidase Company Manufacturing Base and Headquarters
  7. 3.7 Global Alpha N-Acetylglucosaminidase Company Product Type and Application
  8. 3.8 Global Alpha N-Acetylglucosaminidase Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Alpha N-Acetylglucosaminidase Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Alpha N-Acetylglucosaminidase Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Alpha N-Acetylglucosaminidase Market by Type
  1. 4.1 Alpha N-Acetylglucosaminidase Type Introduction
  2. 4.1.1 Lesinidase Alfa
  3. 4.1.2 EGT-201
  4. 4.1.3 BMN-250
  5. 4.1.4 ABO-101
  6. 4.1.5 Others
  7. 4.2 Global Alpha N-Acetylglucosaminidase Sales Volume by Type
  8. 4.2.1 Global Alpha N-Acetylglucosaminidase Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Alpha N-Acetylglucosaminidase Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Alpha N-Acetylglucosaminidase Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Alpha N-Acetylglucosaminidase Sales Value by Type
  12. 4.3.1 Global Alpha N-Acetylglucosaminidase Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Alpha N-Acetylglucosaminidase Sales Value by Type (2021-2032)
  14. 4.3.3 Global Alpha N-Acetylglucosaminidase Sales Value Share by Type (2021-2032)
5 Alpha N-Acetylglucosaminidase Market by Application
  1. 5.1 Alpha N-Acetylglucosaminidase Application Introduction
  2. 5.1.1 In-Patient
  3. 5.1.2 Out-Patient
  4. 5.2 Global Alpha N-Acetylglucosaminidase Sales Volume by Application
  5. 5.2.1 Global Alpha N-Acetylglucosaminidase Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Alpha N-Acetylglucosaminidase Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Alpha N-Acetylglucosaminidase Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Alpha N-Acetylglucosaminidase Sales Value by Application
  9. 5.3.1 Global Alpha N-Acetylglucosaminidase Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Alpha N-Acetylglucosaminidase Sales Value by Application (2021-2032)
  11. 5.3.3 Global Alpha N-Acetylglucosaminidase Sales Value Share by Application (2021-2032)
6 Alpha N-Acetylglucosaminidase Regional Sales and Value Analysis
  1. 6.1 Global Alpha N-Acetylglucosaminidase Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Alpha N-Acetylglucosaminidase Sales by Region (2021-2032)
  3. 6.2.1 Global Alpha N-Acetylglucosaminidase Sales by Region: 2021-2026
  4. 6.2.2 Global Alpha N-Acetylglucosaminidase Sales by Region (2027-2032)
  5. 6.3 Global Alpha N-Acetylglucosaminidase Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Alpha N-Acetylglucosaminidase Sales Value by Region (2021-2032)
  7. 6.4.1 Global Alpha N-Acetylglucosaminidase Sales Value by Region: 2021-2026
  8. 6.4.2 Global Alpha N-Acetylglucosaminidase Sales Value by Region (2027-2032)
  9. 6.5 Global Alpha N-Acetylglucosaminidase Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Alpha N-Acetylglucosaminidase Sales Value (2021-2032)
  12. 6.6.2 North America Alpha N-Acetylglucosaminidase Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Alpha N-Acetylglucosaminidase Sales Value (2021-2032)
  15. 6.7.2 Europe Alpha N-Acetylglucosaminidase Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Alpha N-Acetylglucosaminidase Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Alpha N-Acetylglucosaminidase Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Alpha N-Acetylglucosaminidase Sales Value (2021-2032)
  21. 6.9.2 South America Alpha N-Acetylglucosaminidase Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Alpha N-Acetylglucosaminidase Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Alpha N-Acetylglucosaminidase Sales Value Share by Country, 2025 VS 2032
7 Alpha N-Acetylglucosaminidase Country-level Sales and Value Analysis
  1. 7.1 Global Alpha N-Acetylglucosaminidase Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Alpha N-Acetylglucosaminidase Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Alpha N-Acetylglucosaminidase Sales by Country (2021-2032)
  4. 7.3.1 Global Alpha N-Acetylglucosaminidase Sales by Country (2021-2026)
  5. 7.3.2 Global Alpha N-Acetylglucosaminidase Sales by Country (2027-2032)
  6. 7.4 Global Alpha N-Acetylglucosaminidase Sales Value by Country (2021-2032)
  7. 7.4.1 Global Alpha N-Acetylglucosaminidase Sales Value by Country (2021-2026)
  8. 7.4.2 Global Alpha N-Acetylglucosaminidase Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Alpha N-Acetylglucosaminidase Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Alpha N-Acetylglucosaminidase Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Alpha N-Acetylglucosaminidase Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Alpha N-Acetylglucosaminidase Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Alpha N-Acetylglucosaminidase Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Alpha N-Acetylglucosaminidase Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Alpha N-Acetylglucosaminidase Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Alpha N-Acetylglucosaminidase Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Alpha N-Acetylglucosaminidase Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Alpha N-Acetylglucosaminidase Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Alpha N-Acetylglucosaminidase Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Alpha N-Acetylglucosaminidase Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Alpha N-Acetylglucosaminidase Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Alpha N-Acetylglucosaminidase Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Alpha N-Acetylglucosaminidase Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Alpha N-Acetylglucosaminidase Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Alpha N-Acetylglucosaminidase Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Alpha N-Acetylglucosaminidase Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Alpha N-Acetylglucosaminidase Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Alpha N-Acetylglucosaminidase Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Alpha N-Acetylglucosaminidase Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Alpha N-Acetylglucosaminidase Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Alpha N-Acetylglucosaminidase Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Alpha N-Acetylglucosaminidase Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Alpha N-Acetylglucosaminidase Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Alpha N-Acetylglucosaminidase Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Alpha N-Acetylglucosaminidase Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Alpha N-Acetylglucosaminidase Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Alpha N-Acetylglucosaminidase Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Alpha N-Acetylglucosaminidase Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Alpha N-Acetylglucosaminidase Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Alpha N-Acetylglucosaminidase Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Alpha N-Acetylglucosaminidase Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Alpha N-Acetylglucosaminidase Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Alpha N-Acetylglucosaminidase Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Alpha N-Acetylglucosaminidase Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Alpha N-Acetylglucosaminidase Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Alpha N-Acetylglucosaminidase Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Alpha N-Acetylglucosaminidase Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Alpha N-Acetylglucosaminidase Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Alpha N-Acetylglucosaminidase Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Alpha N-Acetylglucosaminidase Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Alpha N-Acetylglucosaminidase Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Alpha N-Acetylglucosaminidase Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Alpha N-Acetylglucosaminidase Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Alpha N-Acetylglucosaminidase Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Alpha N-Acetylglucosaminidase Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Alpha N-Acetylglucosaminidase Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Alpha N-Acetylglucosaminidase Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Alpha N-Acetylglucosaminidase Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Alpha N-Acetylglucosaminidase Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Alpha N-Acetylglucosaminidase Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Alpha N-Acetylglucosaminidase Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Alpha N-Acetylglucosaminidase Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Alpha N-Acetylglucosaminidase Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Alpha N-Acetylglucosaminidase Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Alpha N-Acetylglucosaminidase Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Alpha N-Acetylglucosaminidase Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Alpha N-Acetylglucosaminidase Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Alpha N-Acetylglucosaminidase Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Alpha N-Acetylglucosaminidase Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Alpha N-Acetylglucosaminidase Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Alpha N-Acetylglucosaminidase Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Alpha N-Acetylglucosaminidase Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Alpha N-Acetylglucosaminidase Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Alpha N-Acetylglucosaminidase Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Alpha N-Acetylglucosaminidase Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Alpha N-Acetylglucosaminidase Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Alpha N-Acetylglucosaminidase Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Alpha N-Acetylglucosaminidase Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Alpha N-Acetylglucosaminidase Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Alpha N-Acetylglucosaminidase Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Alpha N-Acetylglucosaminidase Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Alpha N-Acetylglucosaminidase Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Alpha N-Acetylglucosaminidase Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Alpha N-Acetylglucosaminidase Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Alpha N-Acetylglucosaminidase Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Alpha N-Acetylglucosaminidase Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Alpha N-Acetylglucosaminidase Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Alpha N-Acetylglucosaminidase Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Alpha N-Acetylglucosaminidase Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Alpha N-Acetylglucosaminidase Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Alpha N-Acetylglucosaminidase Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Alpha N-Acetylglucosaminidase Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 UniQure N.V.
  2. 8.1.1 UniQure N.V. Company Information
  3. 8.1.2 UniQure N.V. Business Overview
  4. 8.1.3 UniQure N.V. Alpha N-Acetylglucosaminidase Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 UniQure N.V. Alpha N-Acetylglucosaminidase Product Portfolio
  6. 8.1.5 UniQure N.V. Recent Developments
  7. 8.2 Laboratorios Del Dr. Esteve S.A.
  8. 8.2.1 Laboratorios Del Dr. Esteve S.A. Company Information
  9. 8.2.2 Laboratorios Del Dr. Esteve S.A. Business Overview
  10. 8.2.3 Laboratorios Del Dr. Esteve S.A. Alpha N-Acetylglucosaminidase Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Laboratorios Del Dr. Esteve S.A. Alpha N-Acetylglucosaminidase Product Portfolio
  12. 8.2.5 Laboratorios Del Dr. Esteve S.A. Recent Developments
  13. 8.3 Dorphan S.A.
  14. 8.3.1 Dorphan S.A. Company Information
  15. 8.3.2 Dorphan S.A. Business Overview
  16. 8.3.3 Dorphan S.A. Alpha N-Acetylglucosaminidase Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Dorphan S.A. Alpha N-Acetylglucosaminidase Product Portfolio
  18. 8.3.5 Dorphan S.A. Recent Developments
  19. 8.4 BioMarin Pharmaceutical Inc.
  20. 8.4.1 BioMarin Pharmaceutical Inc. Company Information
  21. 8.4.2 BioMarin Pharmaceutical Inc. Business Overview
  22. 8.4.3 BioMarin Pharmaceutical Inc. Alpha N-Acetylglucosaminidase Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 BioMarin Pharmaceutical Inc. Alpha N-Acetylglucosaminidase Product Portfolio
  24. 8.4.5 BioMarin Pharmaceutical Inc. Recent Developments
  25. 8.5 Alexion Pharmaceuticals, Inc.
  26. 8.5.1 Alexion Pharmaceuticals, Inc. Company Information
  27. 8.5.2 Alexion Pharmaceuticals, Inc. Business Overview
  28. 8.5.3 Alexion Pharmaceuticals, Inc. Alpha N-Acetylglucosaminidase Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Alexion Pharmaceuticals, Inc. Alpha N-Acetylglucosaminidase Product Portfolio
  30. 8.5.5 Alexion Pharmaceuticals, Inc. Recent Developments
  31. 8.6 Abeona Therapeutics, Inc.
  32. 8.6.1 Abeona Therapeutics, Inc. Company Information
  33. 8.6.2 Abeona Therapeutics, Inc. Business Overview
  34. 8.6.3 Abeona Therapeutics, Inc. Alpha N-Acetylglucosaminidase Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Abeona Therapeutics, Inc. Alpha N-Acetylglucosaminidase Product Portfolio
  36. 8.6.5 Abeona Therapeutics, Inc. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Alpha N-Acetylglucosaminidase Value Chain Analysis
  2. 9.1.1 Alpha N-Acetylglucosaminidase Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Alpha N-Acetylglucosaminidase Sales Mode & Process
  6. 9.2 Alpha N-Acetylglucosaminidase Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Alpha N-Acetylglucosaminidase Distributors
  9. 9.2.3 Alpha N-Acetylglucosaminidase Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst